Virtu Financial’s OptimizeRx OPRX Stock Holding History

Virtu Financial’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,827	Closed	-$74K	–	2072
2026 Q1	$74K	Buy	+11,827	New	+$110K	﹤0.01%	1224
2025 Q2	–	Sell	-12,956	Closed	-$112K	–	1886
2025 Q1	$112K	Buy	+12,956	New	+$79.2K	0.01%	913
2021 Q4	–	Sell	-13,375	Closed	-$1.14M	–	2052
2021 Q3	$1.14M	Buy	13,375 +5,647	+73%	+$354K	0.1%	196
2021 Q2	$478K	Buy	+7,728	New	+$393K	0.05%	501

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Virtu Financial's OPRX Position: Q2 2026 in Review

Virtu Financial sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 11,827 shares — an estimated $74K sold.

Virtu Financial first reported a position in OPRX in Q2 2021 and held it in 4 quarters. The position peaked at $1.14M in Q3 2021. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

Virtu Financial reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 11,827 OptimizeRx shares in Q2 2026, an estimated $74K.
Virtu Financial first reported a position in OptimizeRx in Q2 2021 and held it in 4 quarters.
Virtu Financial's OptimizeRx position peaked at $1.14M in Q3 2021.
112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.